Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prenetics Global Limited - Class A Ordinary Share (NQ: PRE )

5.825 +0.015 (+0.26%)
Streaming Delayed Price Updated: 12:58 PM EDT, Jul 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prenetics Global Limited - Class A Ordinary Share

< Previous 1 2 3 Next >
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness 
From Prenetics Limited
Via GlobeNewswire
Prenetics Global Limited (NASDAQ: PRE): Genomic Innovations Making Waves in Cancer Care
Via AB Newswire
Prenetics Global Limited: Genomic Innovations Making Waves in Cancer Care”
Prenetics Global Limited: Genomic Innovations Making Waves in Cancer Care” 
Via News Direct
PRE Stock Earnings: Prenetics Global Reported Results for Q1 2024
Prenetics Global just reported results for the first quarter of 2024. 
Via InvestorPlace
Prenetics Announces First Quarter 2024 Financial Results
From Prenetics Limited
Via GlobeNewswire
Prenetics Global: Q4 Earnings Insights
Via Benzinga
Prenetics Global: Q3 Earnings Insights
Via Benzinga
Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
~ Emphasizes Strong Cash Position, No Debt, and A Dedicated Management Team Focused on Delivering Growth and Value to Shareholders ~ 
From Prenetics Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
PRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023
PRE stock results show that Prenetics Global beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
From Prenetics Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
From Prenetics Limited
Via GlobeNewswire
5 Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Prenetics Announces Third Quarter 2023 Financial Results
From Prenetics Limited
Via GlobeNewswire
Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday. 
Via Benzinga
Prenetics Global Limited Announces Reverse Stock Split
From Prenetics Limited
Via GlobeNewswire
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Prenetics Announces Second Quarter 2023 Financial Results
From Prenetics Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV 
Via News Direct
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV
Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor... 
Via TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT 
From Prenetics Limited
Via GlobeNewswire
EXCLUSIVE: Prenetics, Professor Dennis Lo Aim To Make Early Cancer Detection 'Universally Accessible Necessity' With $200M Joint Venture
Prenetics Global Limited (NASDAQ: PRE), a genomics and precision oncology company, and Professor Dennis Lo announced Sunday they have entered a partnership to establish an early cancer detection... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.